# SIGHI Medication Manual - Table of Contents
 
SIGHI Medication Manual: Medical treatment in histaminosis 
 
Information about mast cell activation diseases (mastocytosis, MCAS),
for persons concerned and healthcare professionals
 
03.01.2019 
 
www.mastzellaktivierung.info
 
**Table of Contents**:
 
* 1 Preliminary remarks 
* 1.1 Disclaimer, disclosure duty 
* 1.2 Abbreviations. Definitions 
* 1.3 Fundamentals of MCAD medical treatment 
* 1.4 Tolerability of medicines 
* 1.4.1 Incompatible active ingredients 
* 1.4.2 Incompatible excipients 
* 2 Overview: Who needs which medication when? 
* 2.1 Medical treatment for systemic mast cell activation disorders (MCAD) 
* 2.1.1 Therapeutic strategy for MCAD 
* 2.1.2 Basic therapy 
* 2.1.3 Symptomatic supplemental treatment 
* 2.1.3.1 Pain 
* 2.1.3.2 Disorders of the digestive tract
* 2.1.3.3 Miscellaneous symptoms and disorders 
* 2.2 Medication for histamine intolerance (DAO associated histamine degradation disorder)22
* 2.2.1 Basic therapy 
* 2.2.2 Symptomatic supplemental treatment 
* 2.2.3 Additional measures in severe cases
* 2.3 Medication for intestinal dysbiosis, small intestinal bacterial overgrowth 
* 3 Medicinal products (Medications) 
* 3.1 Antihistamines (histamine receptor antagonists) 
* 3.1.1 H1 antihistamines (H1 receptor antagonists) 
* 3.1.1.1 Bilastine 
* 3.1.1.2 Cetirizine 
* 3.1.1.3 Clemastine (Tavegyl®) 
* 3.1.1.4 Desloratadine (= descarboethoxyloratadine, DCL)
* 3.1.1.5 Dimenhydrinate 
* 3.1.1.6 Dimetindene (dimethindene) (CH: Feniallerg®, D: Fenistil®) 
* 3.1.1.7 Diphenhydramine 
* 3.1.1.8 Fexofenadine 
* 3.1.1.9 Hydroxizine 
* 3.1.1.10 Ketotifen (Zaditen®) 
* 3.1.1.11 Levocetirizine, levocetirizine dihydrochloride (Xyzal®) 
* 3.1.1.12 Loratadine 
* 3.1.1.13 Rupatadine 
* 3.1.2 H2-antihistamines (H2-receptor antagonists), ranitidine 
* 3.1.3 Other antihistaminergic agents 
* 3.2 Mast cell stabilizers 
* 3.2.1 Cromoglicinic acid, sodium cromoglicate 
* 3.2.1.1 Nalcrom®
* 3.2.2 Ketotifen (Zaditen®) 
* 3.3 Prostaglandin synthesis inhibitors, nonsteroidal antiinflammatory drugs (NSAIDs) △ 
* 3.3.1 Ibuprofen △ 
* 3.3.2 Dexibuprofen △ 
* 3.3.3 Acetylsalicylic acid (ASS) △
* 3.3.4 Etoricoxib (Arcoxia®) 
* 3.3.5 Celecoxib (Celebrex®) 
* 3.4 Leukotriene inhibitors 
* 3.5 Analgesics 
* 3.5.1 Paracetamol (Acetaminophen) 
* 3.6 Proton pump inhibitors
* 3.7 Cannabinoids, cannabinoid receptor agonists 
* 3.7.1 Hemp, cannabis 
* 3.7.2 Tetrahydrocannabinol (THC) 
* 3.7.3 Cannabidiol (CBD) 
* 3.7.4 Palmitoylethanolamide (PEA) 
* 3.8 Opiates, opioids △ 
* 3.9 Psychiatric medications 
* 3.9.1 Antidepressants
* 3.9.2 Neuroleptics, antipsychotics
* 3.9.3 Benzodiazepines
* 3.10 Immunosuppressants, immunomodulators 
* 3.10.1 Glucocorticoids 
* 3.10.1.1 Natural Glucocorticoids 
* 3.10.1.2 Synthetic glucocorticoids 
* 3.10.2 Azathioprine 
* 3.10.3 Methotrexate
* 3.11 Anti-IgE monoclonal antibodies 
* 3.11.1 Omalizumab 
* 3.12 Tyrosine kinase inhibitors, inhibitors of other kinases 
* 3.12.1 Imatinib
* 3.12.2 Masitinib 
* 3.12.3 Midostaurin
* 3.12.4 Crenolanib
* 3.12.5 Sunitinib
* 3.12.6 Nilotinib 
* 3.12.7 Dasatinib 
* 3.13 Cytoreductive therapy, chemotherapy, cytostatics 
* 3.13.1 Interferon-α 
* 3.13.2 Cladribine 
* 3.13.3 Hydroxyurea
* 3.13.4 Thalidomide 
* 3.14 Stem cell transplantation 
* 4 Medical devices
* 4.1 Clinoptilolite, zeolite
* 5 Foods for special medical purposes 
* 5.1 Diamine oxidase (DAO) 
* 5.1.1 DAOSIN® 
* 5.2 Probiotics
* 5.2.1 Lactopia Probio Histamed®
* 6 Nutritional supplements 
* 6.1 Vitamin C
* 6.2 Vitamin D3 (cholecalciferol) 
* 6.3 Zinc 
* 6.4 Natural mast cell stabilizers 
* 6.4.1 Chondroitin sulfate, chondroitin 
* 6.4.2 Flavonoids △ 
* 6.4.2.1 Quercetin △ 
* 6.4.3 Curcumin 
* 6.4.4 Stilbene derivatives (stilbenoids) 
* 6.4.5 Ellagic acid 
* 6.5 Selenium 
* 7 Preparations for an emergency 
* 7.1 Anaphylaxis, anaphylactic shock 
* 7.1.1 Definitions 
* 7.1.2 Gradation of severity 
* 7.2 Interventions in anaphylactic / anaphylactoid shock 
* 7.3 Emergency kit 
* 7.3.1 Content of the emergency kit 
* 7.3.2 Use of the emergency kit 
* 7.3.2.1 At ONSET of reaction 
* 7.3.2.2 In case of a SEVERE reaction 
* 7.4 Medical alert card 
* 7.5 Living will 
* 8 Premedication before medical interventions 
* 8.1 Rationale for the need for premedication 
* 8.2 Anesthesia / surgery / invasive examinations 
* 8.2.1 General considerations 
* 8.2.2 Prior to an operation (= preoperative) 
* 8.2.3 During an operation (= intraoperative) 
* 8.2.4 After an operation (= postoperative) 
* 8.2.5 Compatibility of frequently used active ingredients in medical interventions 
* 8.3 local anaesthesia, regional anaesthesia 
* 8.4 Examinations containing contrast medium (X-ray, CT, MRI) 
* 8.5 Dental medicine and MCAD / Histaminosis 
* 8.5.1 Premedication in dentistry
* 8.5.2 General information for the dentist 
* 8.5.3 Tolerable products for local anesthesia in dentistry 
* 8.5.3.1 Switzerland 
* 8.5.3.2 Germany 
* 8.5.3.3 Austria 
* 8.6 Vaccinations 
* 8.6.1 Compatibility of vaccinations in MCAD
* 8.6.2 To vaccinate: yes or no? 
* 8.6.3 Self-centered versus societal considerations 
* 8.6.4 Compulsory vaccination 
* 8.6.5 Precautions for vaccinations 
* 9 Medicinal treatment in the event of disease
* 9.1 Flu-like infection, common cold, sore throat, bacterial infection
* 9.1.1 Antipyretics, cold medication
* 9.1.2 Sore throat 
* 9.1.3 Nutritional supplementation 
* 9.1.4 Bacterial secondary infections (frontal and maxillary sinusitis) 
* 9.1.5 Inappropriate for infections
* 9.2 Antibiotics
* 9.3 Allergies
* 9.3.1 Respiratory allergies
* 9.4 Swallowing disorders, dysphagia 
* 10 Medicinal treatment in special situations
* 10.1 Pregnancy and lactation 
* 10.1.1 Medicinal treatment for pregnant and lactating women
* 10.1.1.1 Recommended substances 
* 10.1.1.2 Less well suited 
* 10.1.1.3 Imperatively to be avoided 
* 10.1.2 Psychiatric medications during pregnancy 
* 11 References 
* 12 Annex
* Annex: incompatible active substances
